Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 17NIH 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 924Neoplasms 614Breast Neoplasms 613Colorectal Neoplasms 452Neoplasm Metastasis 398Ovarian Neoplasms 333Melanoma 316Prostatic Neoplasms 315Lung Neoplasms 293Multiple Myeloma 292Recurrence 280Squamous Cell Carcinoma of Head and Neck 247Stomach Neoplasms 232Pancreatic Neoplasms 231Leukemia, Myeloid, Acute 223Triple Negative Breast Neoplasms 192Endometrial Neoplasms 191Carcinoma, Renal Cell 183Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 164Leukemia, Lymphocytic, Chronic, B-Cell 158Advanced Solid Tumors 157Lymphoma, Follicular 150Lymphoma, Large B-Cell, Diffuse 141Urinary Bladder Neoplasms 140Lymphoma 138Advanced Solid Tumor 137Uterine Cervical Neoplasms 135Glioblastoma 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neutropenia × 1 year × Clear all
NCT04448301 2025-11-06

PC001- A Study to Evaluate the Usability of PointCheck

Leuko Labs, Inc.

Phase NA Completed
81 enrolled

Neoplasms, Neutropenia

NCT04618081 2025-07-08

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Celgene

Completed
151 enrolled
Lymphoid

Bone Marrow Failure Disorders, Lymphoma, Lymphoma, Non-Hodgkin, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡